Project Grant R01AI194917
Award Date
8/1/25
Completion Date
7/31/30
Dollars Obligated
$648K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Farmington, CT 06030, USA
Similar Awards
This $537,619 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports the development of a novel electrochemical biosensor technology capable of simultaneously detecting HIV, hepatitis B, and hepatitis C viruses. The project aims to integrate the recently developed four-way junction (4WJ) electrochemical biosensor with an isothermal nucleic acid amplification technique to create a...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $354,570 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Case Western Reserve University (CWRU) for the development of a cost-effective, user-friendly point-of-care (POC) diagnostic tool for HIV and hepatitis B virus (HBV) co-infection. The project aims to create a microchip-based "CamoChip" technology that integrates serological and molecular tests for HIV and HBV into...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded Emory University a $2,082,247 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop an economical, rapid molecular diagnostic system for detecting hepatitis C virus (HCV) and HIV from whole blood samples. The research aims to overcome barriers to low-cost implementation of molecular diagnostics for RNA viruses by creating novel chemistries and microfluidics to enable minimally...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports the development of an alternative isothermal DNA amplification technique. The $151,496 award to the University of Central Florida will fund research to create a novel DNA amplification method using double-stranded primers that can produce high concentrations of amplified DNA similar to PCR, but without the need...
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded Colorado State University a $340,408 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop and validate an assay for precision antiretroviral therapy to combat drug resistance in HIV patients. The key products and services to be delivered under this award include: Improving the throughput and capacity of an existing infectivity assay using proviral constructs with an H2B-mRFP...
This Project Grant award of $1,454,386.00 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports fundamental research to better understand the epigenetic regulation of the HIV-1 viral RNA cap. The research aims to define the structural basis of HIV cap hypermethylation and its linkage to modulating host innate immune signaling, with the goal of developing new treatments to neutralize deleterious...
This $1,413,007 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support the development and evaluation of the CRISPR-TB diagnostic tool for detecting tuberculosis (TB) in children under 5 years old. The University of Washington is the primary grantee and will lead a large prospective study of 400 children with suspected TB. The project aims to expand upon prior successful...
The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), awarded a $603,338 Project Grant to Yale University. The grant supports research to understand how the human immunodeficiency virus 1 (HIV-1) mediates fusion with host cells, specifically investigating the interactions between the viral envelope glycoprotein (Env), cellular receptors CD4 and CCR5/CXCR4, and cell membranes. Using...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $486,057 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The 5-year grant, awarded on June 6, 2025, will support the development of a multipronged mRNA gene therapy approach to address HIV persistence and enable a potential cure. The proposed research aims...
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a $781,367 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Weill Medical College of Cornell University. The grant, awarded on January 25, 2024, will support research to define and maximize the impact of CD8+ T-cell selection on the landscape of HIV integration sites. The goal is to optimize strategies for eradicating the persistent reservoir of HIV-infected cells and achieve...